SYKT Alleviates Doxorubicin-Induced Cardiotoxicity via Modulating ROS-Mediated p53 and MAPK Signal Pathways
about
SYKT Alleviates Doxorubicin-Induced Cardiotoxicity via Modulating ROS-Mediated p53 and MAPK Signal Pathways
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 26 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
SYKT Alleviates Doxorubicin-In ...... d p53 and MAPK Signal Pathways
@en
SYKT Alleviates Doxorubicin-In ...... d p53 and MAPK Signal Pathways
@nl
type
label
SYKT Alleviates Doxorubicin-In ...... d p53 and MAPK Signal Pathways
@en
SYKT Alleviates Doxorubicin-In ...... d p53 and MAPK Signal Pathways
@nl
prefLabel
SYKT Alleviates Doxorubicin-In ...... d p53 and MAPK Signal Pathways
@en
SYKT Alleviates Doxorubicin-In ...... d p53 and MAPK Signal Pathways
@nl
P2093
P2860
P356
P1476
SYKT Alleviates Doxorubicin-In ...... d p53 and MAPK Signal Pathways
@en
P2093
Ruilian Zhao
Zhiyong Deng
P2860
P304
P356
10.1155/2018/2581031
P407
P577
2018-08-26T00:00:00Z